Purchase Order 75N95023P00575
Award Date 9/1/23
Potential Completion Date 8/31/24
Potential Value $79K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Albany, NY 12203, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $13,300 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS) to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The contract is for X-ray crystallography studies of ALDH1A2 in complex with a small molecule inhibitor, as part of NCATS' drug discovery and development efforts. No set-aside designation was used. Curia has extensive experience supporting various...
- This federal contract award is for "CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL" and was issued to Curia Global Inc., doing business as Amri. The contract, valued at $907,791.77, is a delivery order under the "CRO Support for NCATS Drug Substance Development and Manufacture" indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The National Center for Advancing Translational...
- Curia Global Inc., doing business as Amri, has been awarded an $11,250 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to provide purification services for McHenry-CNA35 (4L). As a leading global contract development and manufacturing organization, Amri will utilize its expertise in medicinal chemistry, chemical development, analytical testing, formulation development, and cGMP...
- This $142,500 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Curia Global Inc., doing business as Amri, a global contract development and manufacturing organization (CDMO). The contract is for sequencing services to identify molecules that bind the KIAA0203 protein, in support of the NIH's preclinical drug discovery efforts. No set-aside designation was used. Curia has provided...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri) for $815,714.07. The contract is for medicinal chemistry services to support the "ALDRICH (UNIV. OF FLORIDA) - EXPLORATORY CHEMISTRY-ADMET ONLY - MCSP" project, which is part of NINDS's Medicinal Chemistry Support Program for therapeutic development. Curia, a...
- This federal contract award to Curia Global Inc., doing business as Amri, is for the development of the drug substance (R)-VK4-116 dihydrochloride salt. The $1,804,267.88 cost-plus-fixed-fee contract was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the Department of Health and Human Services. This contract is a delivery order under the NCATS' larger "CRO Support for NCATS Drug Substance Development and Manufacture"...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), on behalf of the National Institute of Neurological Disorders and Stroke (NINDS), to Curia Global Inc. (doing business as Amri) for the non-GMP synthesis of up to 100 compounds in 2-10 milligram quantities. The purpose is to identify molecules that bind the KIAA0203 protein, which could potentially lead to the development of a new Alzheimer's drug. The contract has a period of performance from...
- This federal contract task order was awarded by the U.S. Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The $1,376,049.53 cost-plus-fixed-fee task order, awarded on August 15, 2018, supports the Medicinal Chemistry Support Program for Therapeutic Development, providing chemistry, manufacturing, and controls...
- This is a delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as Amri, for the Medicinal Chemistry Support Program for Therapeutic Development. The contract, with a potential value of $4,042,434.33, provides chemistry, manufacturing, and controls development; exploratory chemistry; hit-to-lead chemistry; absorption/distribution/metabolism/excretion testing; process...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $1.5 million delivery order contract to Curia Global Inc., doing business as Amri, for TSUKAMOTO (JOHNS HOPKINS UNIVERSITY) MCSP - LEAD OPTIMIZATION CHEMISTRY. The prime contractor, Amri, will perform lead optimization chemistry services in Albany, New York for the agency from September 2023 through March 2025. The contract uses a cost plus fixed fee pricing...